Nonalcoholic Steatohepatitis [dsyn]    
At risk [qlco]    
Aims [idcn]    
Excess [qlco]    
Hepatic [blor]    
Contribute [acty]    
pathogenesis [ftcn]    
Nonalcoholic Steatohepatitis [dsyn]    
cholesterol synthesis [moft]    
Study [mnob]    
Histological [ftcn]    
LIVER DAMAGE [patf]    
Related [qlco]    
Steatohepatitis [dsyn]    
Methods [inpr]    
Relationship [qlco]    
genetic risk factors [qlco]    
LIVER DAMAGE [patf]    
Assessed [acty]    
Multi [qnco]    
Centre [spco]    
EUROPEAN [popg]    
Liver Biopsy [diap]    
Suspected [qlco]    
Nonalcoholic Steatohepatitis [dsyn]    
Record [inpr]    
Subject [grup]    
Protection [fndg]    
Steatosis [patf]    
Fibrosis stage [clna]    
F2 [qnco]    
Dose-dependent [qnco]    
Adjusted [ftcn]    
Treated [ftcn]    
Patients [podg]    
matched [resa]    
Modality [idcn]    
Recruitment [acty]    
Gender [orga]    
IFG [gngm]    
Type II Diabetes [dsyn]    
PNPLA3 [gngm]    
Alleles [gngm]    
TM6SF2 [gngm]    
Variant [qlco]    
Protection [fndg]    
Steatosis [patf]    
Steatohepatitis [dsyn]    
Fibrosis stage [clna]    
F2 [qnco]    
confirmed [qlco]    
Second [qnco]    
matched [resa]    
Recruitment [acty]    
Centre [spco]    
Steatohepatitis [dsyn]    
Strong [qlco]    
Subject [grup]    
Carrying [acty]    
PNPLA3 [gngm]    
Variant [qlco]    
Interaction [ftcn]    
Steatohepatitis [dsyn]    
Patients [podg]    
Negative [qlco]    
Variant [qlco]    
P s [ortf]    
Conclusions [idcn]    
Protection [fndg]    
Full spectrum [qlco]    
LIVER DAMAGE [patf]    
Nonalcoholic Steatohepatitis [dsyn]    
PNPLA3 [gngm]    
Variant [qlco]    
Limited [ftcn]    
EUROPEAN [popg]    
Association [menp]    
Study [mnob]    
LIVER [bpoc]    
Published [ocac]    
rights [qlco]    
Reserve [acty]    
